Conserved influenza A viral mRNA regions (IAV mRNA)

Conserved influenza A viral mRNA regions are highly stable nucleotide sequences within the messenger RNA of the Influenza A virus (IAV) that remain unchanged across various strains and subtypes (Source: PubMed, PMID: 25653431). These regions are essential for the virus because they often encode critical proteins or form secondary structures required for viral replication and translation (Source: NIH, PMC4324270). Because these sequences are functionally constrained, they are less likely to undergo mutations that lead to drug resistance, making them ideal targets for broad-spectrum antiviral development. Therapeutic strategies targeting these regions include antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) that bind to the mRNA to trigger its degradation or block the translation machinery (Source: Nature, 10.1038/s41598-017-01124-2). By inhibiting the production of viral proteins, these agents can effectively stop the viral life cycle across multiple IAV subtypes, including those with pandemic potential. This approach represents a shift from targeting rapidly mutating surface proteins like hemagglutinin to targeting the fundamental genetic blueprint of the virus.

Other names

Conserved IAV mRNAInfluenza A virus mRNA conserved sequencesIAV mRNA segments

Therapeutic agents bind to conserved sequences in the viral mRNA, leading to RNA degradation via RNase H or the RNA-induced silencing complex (RISC), or physical blockage of the ribosome, which inhibits the translation of essential viral proteins (Source: PubMed, PMID: 25653431).